karppaus.info

WHAT IS ALREADY KNOWN ON THIS TOPIC
-The idea of drug-free remission of type 2 diabetes (T2D) gives hope to many and can be achieved in different ways.

-Sugary and starchy foods worsen blood glucose control so a low-carbohydrate diet is a logical first step.

WHAT THIS STUDY ADDS
-Advice and ongoing guidance on a low-carbohydrate diet in primary care can achieve improved diabetic control for 97% of those interested in the approach, sustained for an average of 33 months.

-Those patients who started with ‘younger’ diabetes and lower HbA1c were far more likely to achieve remission.

Those in the non-remission, ‘mitigation’ group achieved unexpectedly greater, clinically important improvements in diabetic control with the diet

HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY
-Seventy-seven per cent of those adopting a low-carbohydrate approach in the first year of their T2D achieved remission. This represents an important ‘window of opportunity’ for further investigation.

-People with established long-term T2D, which may be poorly controlled could benefit from looking carefully at reducing sugar and starchy carbohydrates.

So proud that ‘The Lifestyle Club’ based on @lowcarbGP’s approach to put T2D into remission, received a Silver @HSJ_Awards for ‘Primary Care Project of the Year’ tonight. A 1st step in our ambition to reverse the T2D epidemic. Amazing team work led by @helenpgowers & @SamFeltham

A small, long-term study of almost 500 children in Massachusetts has found that regularly drinking sugary drinks and 100% fruit juices during childhood and adolescence may be linked to a higher risk of developing Type 2 diabetes among boys than girls, according to preliminary research to be presented at the American Heart Association's Epidemiology and Prevention│Lifestyle and Cardiometabolic Scientific Sessions 2024, March 18- 21, in Chicago. The meeting offers the latest science on population-based health and wellness and implications for lifestyle.

While these findings are preliminary, they support the existing evidence about the potential relationship between beverages with added sugar and long-term risk of Type 2 diabetes in children. Pediatricians and other health care professionals should caution young patients and their parents about sugary drinks and fruit juices when discussing healthy eating habits."

Soren Harnois-Leblanc, Ph.D., lead investigator, registered dietitian and postdoctoral researcher in the department of population medicine at Harvard Pilgrim Health Care Institute and Harvard Medical School
According to a 2022 American Heart Association fact sheet about sugary drinks, nearly two-thirds of children and adolescents in the U.S. consume at least one sugary drink, such as soda, lemonade or an energy drink, each day. It also notes that in addition to weight gain, eating too many foods with added sugars, especially from sugary drinks, raises the risk of developing heart disease, high blood pressure, Type 2 diabetes and tooth decay.

Let's sit down and have a serious discussion about this @AmDiabetesAssn. I believe some within the ADA have people with diabetes' best interests at heart.

- You must know about research by @virtahealth showing low-carb is the way for people with diabetes.

- @lowcarbGP also has years of research to share.

- Low-Carb is already in your guidelines

-read the comments on my YouTube diabetes videos

So why is this the diet advice you loudly promote? Millions of people want to know you answer...
Schedule @DrBobGabbay to discuss this on my YouTube channel before this gets even worse @ChuckatADA

Together, we can save millions of people all over the world from the ravages of diabetes...

Tyypin 2 diabeetikolle ja esidiabeetikoille suositellaan suomalaisen ravitsemussuosituksen mukaista ruokavaliota, jonka löydät googlaamalla helposti netistä.

Someraivo repesi Yhdysvalloissa, kun ADA:n Stacey suositteli tyypin 2 diabeetikoille about virallisten hiilaripainotteisten suositusten mukaista ruokavaliota.

En ole havainnut Suomessa kenenkään reagoineen siihen, kun Laatikainen Apu-lehdessä jakaa jokseenkin samanlaisia ohjeita.

https://www.apu.fi/kysymykset/verensoke ... ja-mita-ei

Study adds new evidence on the link between Type 2 diabetes and Alzheimer's disease

New research conducted in mice offers insights into what's going on at the molecular level that could cause people with diabetes to develop Alzheimer's disease.

The study adds to a growing body of research on the links between Type 2 diabetes and Alzheimer's disease, which some scientists have called "Type 3 diabetes." The findings suggest that it should be possible to reduce the risk of Alzheimer's by keeping diabetes well controlled or avoiding it in the first place, according to researchers.

Narendra Kumar, an associate professor at Texas A&M University in College Station, led the study.

We think that diabetes and Alzheimer's disease are strongly linked, and by taking preventative or amelioration measures for diabetes, we can prevent or at least significantly slow down the progression of the symptoms of dementia in Alzheimer's disease."

Narendra Kumar, Associate Professor, Texas A&M University
Kumar will present the new research at Discover BMB, the annual meeting of the American Society for Biochemistry and Molecular Biology, which is being held March 23–26 in San Antonio.

Abstract
There is a scarcity of information on the population with diabetes mellitus type 2 and cardiomyopathy (PDMC) in COVID-19, especially on the association between anti-diabetic medications and COVID-19 outcomes. Study is designed as a retrospective cohort analysis covering 2020 and 2021. Data from National Diabetes Registry (CroDiab) were linked to hospital data, primary healthcare data, the SARS-CoV-2 vaccination database, and the SARS-CoV-2 test results database. Study outcomes were cumulative incidence of SARS-CoV-2 positivity, COVID-19 hospitalizations, and COVID-19 deaths. For outcome predictors, logistic regression models were developed. Of 231 796 patients with diabetes mellitus type 2 in the database, 14 485 patients had cardiomyopathy. The two2-year cumulative incidence of all three studies' COVID-19 outcomes was higher in PDMC than in the general diabetes population (positivity 15.3% vs. 14.6%, p = 0.01; hospitalization 7.8% vs. 4.4%, p < 0.001; death 2.6% vs. 1.2%, p < 0.001). Sodium-Glucose Transporter 2 (SGLT-2) inhibitors therapy was found to be protective of SARS-CoV-2 infections [OR 0.722 (95% CI 0.610–0.856)] and COVID-19 hospitalizations [OR 0.555 (95% CI 0.418–0.737)], sulfonylureas to be risk factors for hospitalization [OR 1.184 (95% CI 1.029–1.362)] and insulin to be a risk factor for hospitalization [OR 1.261 (95% CI 1.046–1.520)] and death [OR 1.431 (95% CI 1.080–1.897)]. PDMC are at greater risk of acquiring SARS-CoV-2 infection and having worse outcomes than the general diabetic population. SGLT-2 inhibitors therapy was a protective factor against SARS-CoV-2 infection and against COVID-19 hospitalization, sulfonylurea was the COVID-19 hospitalization risk factor, while insulin was a risk factor for all outcomes. Further research is needed in this diabetes sub-population.